Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
Truist Financial
TFC
|
+$351M |
| 3 |
Mastercard
MA
|
+$218M |
| 4 |
PPL
PPL Corp
PPL
|
+$193M |
| 5 |
Cognizant
CTSH
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
IBM
IBM
|
+$320M |
| 3 |
Wells Fargo
WFC
|
+$306M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Financials | 13.92% |
| 3 | Healthcare | 13.77% |
| 4 | Consumer Discretionary | 10.1% |
| 5 | Industrials | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $15.3M | ﹤0.01% |
310,507
+35,596
| +13% | +$1.75M |
|
1727
Central Garden & Pet Co Class A
CENTA
$2.37B
| $15.3M | ﹤0.01% |
651,226
-15,509
| -2% | -$348K |
|
|
ANAT
1728
DELISTED
American National Group, Inc. Common Stock
ANAT
| $15.3M | ﹤0.01% |
129,940
+46,265
| +55% | +$5.47M |
|
1729
OFG Bancorp
OFG
$2.28B
| $15.2M | ﹤0.01% |
644,757
-37,795
| -6% | -$825K |
|
1730
DNOW Inc
DNOW
$2.97B
| $15.2M | ﹤0.01% |
1,353,389
+52,313
| +4% | +$584K |
|
|
P
1731
Everpure Inc
P
$39.3B
| $15.2M | ﹤0.01% |
888,554
+23,841
| +3% | +$422K |
|
1732
First Bancorp
FBNC
$2.74B
| $15.2M | ﹤0.01% |
380,086
+185,658
| +95% | +$7.11M |
|
1733
Axsome Therapeutics
AXSM
$11.2B
| $15.2M | ﹤0.01% |
146,625
-17,826
| -11% | -$720K |
|
1734
Constellium
CSTM
$4.01B
| $15.2M | ﹤0.01% |
1,130,845
+1,115,302
| +7,176% | +$15.4M |
|
1735
Open Text
OTEX
$5.94B
| $15.1M | ﹤0.01% |
343,294
-108,303
| -24% | -$4.55M |
|
|
VRTU
1736
DELISTED
Virtusa Corporation
VRTU
| $15.1M | ﹤0.01% |
332,947
+6,625
| +2% | +$270K |
|
1737
Snap
SNAP
$9.15B
| $15.1M | ﹤0.01% |
923,742
-9,602
| -1% | -$141K |
|
1738
Tompkins Financial
TMP
$1.46B
| $15.1M | ﹤0.01% |
164,544
-14,425
| -8% | -$1.25M |
|
1739
WIX.com
WIX
$3.1B
| $15M | ﹤0.01% |
122,666
-2,953
| -2% | -$361K |
|
1740
Ambev
ABEV
$43.2B
| $15M | ﹤0.01% |
3,221,616
+40,743
| +1% | +$181K |
|
1741
Credicorp
BAP
$30.7B
| $15M | ﹤0.01% |
70,375
-2,769
| -4% | -$580K |
|
1742
ProPetro Holding
PUMP
$1.49B
| $14.9M | ﹤0.01% |
1,328,481
+284,586
| +27% | +$2.54M |
|
1743
ePlus
PLUS
$2.31B
| $14.9M | ﹤0.01% |
352,584
-9,956
| -3% | -$406K |
|
1744
Acushnet Holdings
GOLF
$5.26B
| $14.8M | ﹤0.01% |
456,153
-70,961
| -13% | -$2.11M |
|
1745
Corcept Therapeutics
CORT
$12.4B
| $14.7M | ﹤0.01% |
1,214,350
-13,473
| -1% | -$188K |
|
|
MFA
1746
MFA Financial
MFA
$926M
| $14.7M | ﹤0.01% |
480,076
-9,002
| -2% | -$275K |
|
1747
MaxLinear
MXL
$7.69B
| $14.7M | ﹤0.01% |
690,573
-97,882
| -12% | -$2.03M |
|
1748
Tandem Diabetes Care
TNDM
$1.58B
| $14.6M | ﹤0.01% |
245,435
-9,326
| -4% | -$575K |
|
|
SMAR
1749
DELISTED
Smartsheet Inc.
SMAR
| $14.6M | ﹤0.01% |
325,615
+36,246
| +13% | +$1.5M |
|
|
HOUS
1750
DELISTED
Anywhere Real Estate
HOUS
| $14.6M | ﹤0.01% |
1,509,834
-139,611
| -8% | -$1.28M |
|
Similar funds
Bank of New York Mellon's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of New York Mellon held 4,341 positions worth $388B, up 6.4% from $364B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bank of New York Mellon's Q4 2019 filing shows 131 new, 1,843 increased, 1,854 reduced and 165 closed positions. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2019 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M.
- Bank of New York Mellon added most to Bristol-Myers Squibb in Q4 2019, an estimated $419M increase.
- Bank of New York Mellon's biggest Q4 2019 reduction was IBM, cutting an estimated $320M.
- Bank of New York Mellon fully exited Celgene Corp in Q4 2019, selling an estimated $592M.
- Bank of New York Mellon's ten largest holdings make up 16% of its $388B portfolio in Q4 2019.
- Bank of New York Mellon opened 131 new positions and closed 165 in Q4 2019.
- Bank of New York Mellon's portfolio value rose 6.4% quarter-over-quarter to $388B.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.